ANI Pharmaceuticals Appoints New Board Member
This article was originally published in Scrip
Executive Summary
ANI Pharmaceuticals Inc. has appointed Peter A. Lankau to its board of directors. Currently Lankau is on the board of advisors of Orchard Venture Partners and chair of the board at Phosphagenics Ltd. Prior to this, he was executive chair at Nautilus Neurosciences, Inc. and before this he was chair and CEO of Logical Therapeutics, Inc. Previously, he was CEO and director of Endo Pharmaceuticals Inc.